Literature DB >> 26790021

Breast Cancer in Transgender Veterans: A Ten-Case Series.

George R Brown1,2.   

Abstract

All known cases of breast cancer in patients with a diagnosis consistent with transgender identification were identified in the Veterans Health Administration (1996-2013). Ten cases were confirmed: seven birth sex females and three birth sex males. Of the three birth sex males, two identified as gender dysphoric male-to-female and one identified as transgender with transvestic fetishism. The birth sex males all presented with late-stage disease that proved fatal, whereas most of the birth sex female transgender veterans presented with earlier stage disease that could be treated. These cases support the importance of screening for breast cancer using standard guidelines in birth sex males and females. Family history of breast cancer should be obtained from transgender people as part of routine care. This report expands the known cases of breast cancer in transgender persons from 5 to 12 (female-to-male) and from 10 to 13 (male-to-female).

Entities:  

Keywords:  breast cancer; gender dysphoria; transgender; veterans

Mesh:

Year:  2015        PMID: 26790021     DOI: 10.1089/lgbt.2014.0123

Source DB:  PubMed          Journal:  LGBT Health        ISSN: 2325-8292            Impact factor:   4.151


  11 in total

Review 1.  Cancer and lesbian, gay, bisexual, transgender/transsexual, and queer/questioning (LGBTQ) populations.

Authors:  Gwendolyn P Quinn; Julian A Sanchez; Steven K Sutton; Susan T Vadaparampil; Giang T Nguyen; B Lee Green; Peter A Kanetsky; Matthew B Schabath
Journal:  CA Cancer J Clin       Date:  2015-07-17       Impact factor: 508.702

Review 2.  Cancer in Transgender People: Evidence and Methodological Considerations.

Authors:  Hayley Braun; Rebecca Nash; Vin Tangpricha; Janice Brockman; Kevin Ward; Michael Goodman
Journal:  Epidemiol Rev       Date:  2017-01-01       Impact factor: 6.222

Review 3.  Interdisciplinary Management of Transgender Individuals at Risk for Breast Cancer: Case Reports and Review of the Literature.

Authors:  Julia Eismann; Yujing J Heng; Kristin Fleischmann-Rose; Adam M Tobias; Jordana Phillips; Gerburg M Wulf; Kari J Kansal
Journal:  Clin Breast Cancer       Date:  2018-11-14       Impact factor: 3.225

Review 4.  Priorities for transgender medical and healthcare research.

Authors:  Jamie Feldman; George R Brown; Madeline B Deutsch; Wylie Hembree; Walter Meyer; Heino F L Meyer-Bahlburg; Vin Tangpricha; Guy TʼSjoen; Joshua D Safer
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2016-04       Impact factor: 3.243

5.  Clinical Characteristics, Experiences, and Outcomes of Transgender Patients With Cancer.

Authors:  Zackory T Burns; Danielle S Bitterman; Subha Perni; Patrick J Boyle; Carly E Guss; Daphne A Haas-Kogan; Kevin X Liu
Journal:  JAMA Oncol       Date:  2021-01-21       Impact factor: 31.777

6.  Cancer's Margins: Trans* and Gender Nonconforming People's Access to Knowledge, Experiences of Cancer Health, and Decision-Making.

Authors:  Evan T Taylor; Mary K Bryson
Journal:  LGBT Health       Date:  2015-11-13       Impact factor: 4.151

Review 7.  Sex Differences and Bone Metastases of Breast, Lung, and Prostate Cancers: Do Bone Homing Cancers Favor Feminized Bone Marrow?

Authors:  Mary C Farach-Carson; Sue-Hwa Lin; Theresa Nalty; Robert L Satcher
Journal:  Front Oncol       Date:  2017-08-07       Impact factor: 6.244

Review 8.  Dietary Isoflavones and Breast Cancer Risk.

Authors:  Samira Ziaei; Reginald Halaby
Journal:  Medicines (Basel)       Date:  2017-04-07

9.  Mammary Myofibroblastoma in a Transgender Patient on Feminizing Hormones: Literature Review and Case Report.

Authors:  Jane O'Bryan; Carolyn Wolf-Gould; Yoshiro Matsuo
Journal:  Transgend Health       Date:  2018-01-01

10.  Experiences of Transgender and Gender Nonbinary Patients in the Emergency Department and Recommendations for Health Care Policy, Education, and Practice.

Authors:  M Kathryn Allison; S Alexandra Marshall; Gray Stewart; Melissa Joiner; Creshelle Nash; M Kathryn Stewart
Journal:  J Emerg Med       Date:  2021-06-25       Impact factor: 1.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.